LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 2, Pages -
Publisher
Springer Nature
Online
2019-02-06
DOI
10.1038/s41419-018-1219-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in vitro resistance
- (2018) Andrea Vazanova et al. Cancer Cell International
- Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma
- (2018) Yafang Pan et al. CLINICA CHIMICA ACTA
- Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents
- (2018) Yichao Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
- (2018) Francesco Sparano et al. SUPPORTIVE CARE IN CANCER
- Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
- (2018) Chendong Yang et al. OncoTargets and Therapy
- Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies
- (2018) Kristen B. McCullough et al. Current Hematologic Malignancy Reports
- Deregulated expression of long non-coding RNA UCA1 in multiple myeloma
- (2017) Lenka Sedlarikova et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451
- (2017) Yi-Bin Meng et al. ONCOLOGY RESEARCH
- LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma
- (2017) Nan Yang et al. Cell Death & Disease
- Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition
- (2017) Joyoti Dey et al. Scientific Reports
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2015) Chungyee Leung-Hagesteijn et al. CANCER CELL
- The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma
- (2015) Bingzong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma
- (2015) Kwan Yeung Wong et al. Molecular Cancer
- H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells
- (2015) HONG SUN et al. ONCOLOGY REPORTS
- Small molecule Mcl-1 inhibitors for the treatment of cancer
- (2015) Johannes Belmar et al. PHARMACOLOGY & THERAPEUTICS
- Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription
- (2015) Wenzhuo Zhuang et al. STEM CELLS
- H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
- (2015) Changkun Liu et al. TUMOR BIOLOGY
- Aflatoxin B1 Promotes Cell Growth and Invasion in Hepatocellular Carcinoma HepG2 Cells through H19 and E2F1
- (2014) Jun Lv et al. Asian Pacific Journal of Cancer Prevention
- MCL-1 dependency of cisplatin-resistant cancer cells
- (2014) Judith Michels et al. BIOCHEMICAL PHARMACOLOGY
- BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer
- (2014) Asuka Sugio et al. GYNECOLOGIC ONCOLOGY
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- Sequence analysis of -subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone
- (2012) D. I. Lichter et al. BLOOD
- Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy
- (2011) Patricia Balsas et al. LEUKEMIA RESEARCH
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- (2010) M Ri et al. LEUKEMIA
- Bortezomib-Resistant Nuclear Factor- B Activity in Multiple Myeloma Cells
- (2008) S. Markovina et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now